Clinical Trial

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, single-arm phase I clinical trial.The study process was divided into: screening period, sampling and production period, NMA-LD chemotherapy , treatment and observation period, and follow-up period.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-12; most recent amendment 2025-09-23.
Status change: Completed → Recruiting 2025-09-23
Status change: Recruiting → Completed 2024-07-24
Trial Details
NCT Number NCT06088472
Lead Sponsor Grit Biotechnology
Collaborators: The Affiliated Hospital of Xuzhou Medical University
Conditions Solid Tumors, Adult
Enrollment 12 participants
Start Date 2021-04-21
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-29